| Parameter | Baseline | ||
| combined treatment (n = 37) | simple injection (n = 28) | All (n = 65) | |
| Age (y ± SD) | 51.7 ± 13.6 | 53.3 ± 12.8 | 52.1 ± 12.7 |
| Sex, n (%) |
|
|
|
| Male | 21 (56.8) | 14 (50.09) | 45 (53.8) |
| Female | 16 (43.2) | 14 (50.0) | 34 (46.2) |
| Study eye characteristics |
|
|
|
| Time(wk) from diagnosis to inclusion (Mean ± SD) | 10.6 ± 6.4 | 14.2 ± 5.1 | 12.3 ± 6.3 |
| BCVA | 0.088 ± 0.079 | 0.090 ± 0.067 | 0.089 ± 0.071 |
| CMT before treated (μm ± SD) | 645 ± 228 | 655 ± 180 | 649 ± 199 |
| CMT after a course of treatment (μm ± SD) | 278 ± 118 | 439 ± 188 | 369 ± 147 |